-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $115

Benzinga·11/17/2026 14:47:52
语音播报
TD Cowen analyst Nicholas Lorusso maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy and raises the price target from $100 to $115.